A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186. (Q46931556)
Jump to navigation
Jump to search
scientific article published on 15 November 2012
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186. |
scientific article published on 15 November 2012 |
Statements
1 reference
A phase I/II study of sorafenib in combination with low dose cytarabine in elderly patients with acute myeloid leukemia or high-risk myelodysplastic syndrome from the National Cancer Institute of Canada Clinical Trials Group: trial IND.186. (English)
1 reference
David A Macdonald
1 reference
Sarit E Assouline
1 reference
Joseph Brandwein
1 reference
Elizabeth A Eisenhauer
1 reference
Stephen Couban
1 reference
Stephen Caplan
1 reference
Alison Foo
1 reference
Wendy Walsh
1 reference
Brian Leber
1 reference
15 November 2012
1 reference
1 reference
54
1 reference
4
1 reference
760-766
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference